文献速递介入腹部MR

术前MRI衍生三维定量肿瘤动脉负荷对接受经动脉化疗栓塞的肝细胞癌患者的预后价值

Prognostic Value of Preoperative MRI-derived 3D Quantitative Tumor Arterial Burden in Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization.
PubMed 文献 · Radiol Imaging Cancer · 2024-01-01

本回顾性研究纳入2013年1月至2020年12月间接受重复经动脉化疗栓塞治疗的355例肝细胞癌患者,术前MRI评估的肿瘤动脉负荷按中位数分为高、低两组。中位随访32.7个月,高肿瘤动脉负荷组经动脉化疗栓塞难治性和无进展生存期均显著差于低组(log-rank P < .001),多因素Cox回归显示高肿瘤动脉负荷是二者的最强独立预测因子(HR分别为2.23和2.30)。

要点

  • 术前MRI三维定量肿瘤动脉负荷高者经动脉化疗栓塞难治性发生更快、无进展生存期更短。
  • 高肿瘤动脉负荷是经动脉化疗栓塞难治性和无进展生存期最强的独立预测因子。
  • 在巴塞罗那临床肝癌分期A期或单发肿瘤患者中,高肿瘤动脉负荷的预测作用尤为明显。

核心结论

  • 术前MRI评估的高肿瘤动脉负荷是肝细胞癌患者接受经动脉化疗栓塞治疗后更快发生难治性和疾病进展的风险因素。

研究设计与样本

  • 回顾性研究,纳入355例经病理或影像确诊的肝细胞癌患者,均于2013年1月至2020年12月间接受重复经动脉化疗栓塞治疗,术前MRI评估肿瘤动脉负荷并按中位数分为高、低两组,采用Cox比例风险模型分析经动脉化疗栓塞难治性和无进展生存期的预测因素。

诊断标准与关键数值

  • 经动脉化疗栓塞难治性定义为连续两次或以上经动脉化疗栓塞治疗后存活病灶超过50%或肿瘤数目增加、肿瘤标志物持续升高、肝外转移或血管侵犯;肿瘤动脉负荷按术前MRI评估,以中位数分为高、低两组。

临床应用与阅片要点

  • 术前MRI可定量评估肿瘤动脉负荷,高肿瘤动脉负荷提示经动脉化疗栓塞后更难治和进展更快。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To investigate the association of tumor arterial burden (TAB) on preoperative MRI with transarterial chemoembolization refractoriness (TACER) and progression-free survival (PFS) in patients with hepatocellular carcinoma (HCC). Materials and Methods This retrospective study included patients with HCC who underwent repeated transarterial chemoembolization (TACE) treatments between January 2013 and December 2020. HCC was confirmed with pathology or imaging, and patients with other tumors, lost follow-up, or with a combination of other treatments were excluded. TACER was defined as viable lesions of more than 50% or increase in tumor number after two or more consecutive TACE treatments, continuous elevation of tumor markers, extrahepatic spread, or vascular invasion. TAB assessed with preoperative MRI was divided into high and low groups according to the median. A Cox proportional hazards model was used to determine the predictors of TACER and PFS. Results A total of 355 patients (median age, 61 years [IQR, 54-67]; 306 [86.2%] men, 49 [13.8%] women) were included. During a median follow-up of 32.7 months, the high TAB group had significantly faster TACER and decreased PFS than the low TAB group (all log-rank P < .001). High TAB was the strongest independent predictor of TACER and PFS in multivariable Cox regression analyses (hazard ratio [HR], 2.23 [95% CI: 1.51, 3.29]; HR, 2.30 [95% CI: 1.61, 3.27], respectively), especially in patients with Barcelona Clinic Liver Cancer stage A or a single tumor. The restricted cubic spline plot demonstrated that the HR of TACER and PFS continuously increased with increasing TAB. Conclusion High preoperative TAB at MRI was a risk factor for faster refractoriness and progression in patients with HCC treated with TACE. Keywords: Interventional-Vascular, MR Angiography, Hepatocellular Carcinoma, Transarterial Chemoembolization, Progression-free Survival, MRI Supplemental material is available for this article. © RSNA, 2024.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Peng G, Huang XY, Wang YN, et al. Prognostic Value of Preoperative MRI-derived 3D Quantitative Tumor Arterial Burden in Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization. Radiol Imaging Cancer. 2024. PMID: 38607280. doi:10.1148/rycan.230167

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。